Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that a new treatment for a type of hair loss called telogen effluvium was tested and shows promise.

Women with type D personality and PCOS experience more stress and use less effective coping strategies.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

Using a special skin cream with gabapentin helped reduce symptoms of a certain scalp condition but didn't change nerve fibers or skin chemicals.

Korean Red Ginseng may help protect hair from damage and promote growth.

Thermal spring waters and their microbes could be good for skin health and treating some skin conditions in skincare products.

Protein profiling of forehead skin can help distinguish between frontal fibrosing alopecia and androgenetic alopecia.

The scalp microbiome is more diverse and may be more important in hair loss than the gut microbiome.

Substance P may contribute to hair loss by increasing oxidative stress and mitochondrial activity in hair follicles.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Probiotics and dietary changes can help treat acne.

Activating Nrf2 protects human hair follicles from oxidative stress and helps prevent hair growth inhibition.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

The 3D-SeboSkin model effectively simulates Hidradenitis suppurativa and is useful for future research.

Dermal Papilla Cells grown in 3D and with stem cells better mimic natural hair growth conditions than cells grown in 2D.

The conclusion introduces a new way to classify skin cysts using their shape and genetic markers.

A new peptide, FOL-005, may help treat excessive hair growth by reducing a hair growth promoter, FGF7.

17β-estradiol may help hair growth by increasing cannabinoid receptor type 1.

Removing Lrig1-positive stem cells in mice causes temporary loss of sebaceous glands.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Fermented papaya and mangosteen in hair care products helped prevent hair loss and improve hair thickness.

Iron deficiency is not more common in women with hair loss, and neurogenic rosacea may need different treatment.

Substance P may worsen acne by increasing inflammation, but corticosteroids might help by reducing this effect.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

Eclipta prostrata, particularly its chloroform fraction, effectively reduces inflammation and arthritis.

Blocking COX, especially COX-2, in the skin can reduce inflammation and pain and may help prevent skin cancer.

Finasteride treatment in male rats causes long-lasting effects on depression-like behavior, brain cell growth, inflammation, and gut bacteria composition.